These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19307513)

  • 1. Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.
    Miksad RA; Gönen M; Lynch TJ; Roberts TG
    J Clin Oncol; 2009 May; 27(13):2245-52. PubMed ID: 19307513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
    Suehisa H; Toyooka S
    Acta Med Okayama; 2009 Oct; 63(5):223-30. PubMed ID: 19893597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA.
    Graziano SL; Lacas B; Vollmer R; Kratzke R; Popper H; Filipits M; Seymour L; Shepherd FA; Rosell R; Veillard AS; Taron M; Pignon JP
    Lung Cancer; 2013 Oct; 82(1):149-55. PubMed ID: 23920379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial.
    Wakelee HA; Schiller JH; Gandara DR
    Clin Lung Cancer; 2006 Jul; 8(1):18-21. PubMed ID: 16870041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant and neoadjuvant chemotherapy in NSCLC: a paradigm shift.
    Betticher DC
    Lung Cancer; 2005 Dec; 50 Suppl 2():S9-16. PubMed ID: 16557669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.
    Douillard JY; Tribodet H; Aubert D; Shepherd FA; Rosell R; Ding K; Veillard AS; Seymour L; Le Chevalier T; Spiro S; Stephens R; Pignon JP;
    J Thorac Oncol; 2010 Feb; 5(2):220-8. PubMed ID: 20027124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for non-small cell lung cancer.
    Solomon B; Bunn PA
    Cancer Invest; 2007 Jun; 25(4):217-25. PubMed ID: 17612931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials.
    Reiman T; Lai R; Veillard AS; Paris E; Soria JC; Rosell R; Taron M; Graziano S; Kratzke R; Seymour L; Shepherd FA; Pignon JP; Sève P
    Ann Oncol; 2012 Jan; 23(1):86-93. PubMed ID: 21471564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
    Wakelee H; Dubey S; Gandara D
    Oncologist; 2007 Mar; 12(3):331-7. PubMed ID: 17405898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.
    Douillard JY; Rosell R; De Lena M; Carpagnano F; Ramlau R; Gonzáles-Larriba JL; Grodzki T; Pereira JR; Le Groumellec A; Lorusso V; Clary C; Torres AJ; Dahabreh J; Souquet PJ; Astudillo J; Fournel P; Artal-Cortes A; Jassem J; Koubkova L; His P; Riggi M; Hurteloup P
    Lancet Oncol; 2006 Sep; 7(9):719-27. PubMed ID: 16945766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer.
    Kato H; Tsuboi M; Kato Y; Ikeda N; Okunaka T; Hamada C
    Int J Clin Oncol; 2005 Jun; 10(3):157-64. PubMed ID: 15990962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
    Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA;
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
    Pepe C; Hasan B; Winton TL; Seymour L; Graham B; Livingston RB; Johnson DH; Rigas JR; Ding K; Shepherd FA;
    J Clin Oncol; 2007 Apr; 25(12):1553-61. PubMed ID: 17442999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial.
    Bennouna J; Senellart H; Hiret S; Vaissiere N; Douillard JY
    Lung Cancer; 2011 Oct; 74(1):30-4. PubMed ID: 21371774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights from the Tenth World Conference on Lung Cancer.
    Evans TL
    Oncologist; 2004; 9(2):232-8. PubMed ID: 15047929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
    Hotta K; Matsuo K; Kiura K; Ueoka H; Tanimoto M
    Curr Opin Oncol; 2006 Mar; 18(2):144-50. PubMed ID: 16462183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
    Dunant A; Pignon JP; Le Chevalier T
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5017s-5021s. PubMed ID: 16000606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4.
    Miura N; Kamita M; Kakuya T; Fujiwara Y; Tsuta K; Shiraishi H; Takeshita F; Ochiya T; Shoji H; Huang W; Ohe Y; Yamada T; Honda K
    Oncotarget; 2016 May; 7(22):33165-78. PubMed ID: 27121206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.
    Butts CA; Ding K; Seymour L; Twumasi-Ankrah P; Graham B; Gandara D; Johnson DH; Kesler KA; Green M; Vincent M; Cormier Y; Goss G; Findlay B; Johnston M; Tsao MS; Shepherd FA
    J Clin Oncol; 2010 Jan; 28(1):29-34. PubMed ID: 19933915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of adjuvant chemotherapy in the treatment of non-small cell lung cancer].
    Szondy K; Egri G
    Magy Onkol; 2006; 50(3):229-32. PubMed ID: 17099782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.